Aemetis (NASDAQ:AMTX) Raised to "Sell" at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX - Free Report) to a sell rating in a research report report published on Wednesday.

Separately, HC Wainwright reissued a "buy" rating and set a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $12.95.

Aemetis Trading Down 3.3 %

Shares of NASDAQ AMTX traded down $0.07 during trading on Wednesday, reaching $2.04. 1,052,317 shares of the company traded hands, compared to its average volume of 817,467. The stock has a market cap of $101.47 million, a P/E ratio of -0.90 and a beta of 1.44. The firm's fifty day simple moving average is $2.78 and its 200 day simple moving average is $2.85. Aemetis has a 12-month low of $2.01 and a 12-month high of $7.03.

Aemetis (NASDAQ:AMTX - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to analysts' expectations of $77.79 million. During the same quarter in the prior year, the business posted ($0.59) earnings per share. As a group, research analysts expect that Aemetis will post -2.07 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AMTX. Clear Harbor Asset Management LLC purchased a new stake in Aemetis during the fourth quarter worth about $44,000. FMR LLC increased its holdings in Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company's stock worth $52,000 after purchasing an additional 9,137 shares during the period. SG Americas Securities LLC acquired a new stake in Aemetis in the 4th quarter valued at about $87,000. Barclays PLC boosted its stake in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock valued at $109,000 after buying an additional 34,816 shares during the period. Finally, Wellington Management Group LLP acquired a new position in shares of Aemetis during the third quarter worth about $177,000. Hedge funds and other institutional investors own 27.02% of the company's stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.